Patents by Inventor Yonggil Kim

Yonggil Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8772299
    Abstract: The present invention relates to novel piperazine derivatives or pharmaceutically acceptable salts thereof, a process for preparing the same, and in particular, a high binding for Serotonin 1A(5-hydroxytryptamine; 5-HT1A) receptor, a pharmaceutical composition for treatment and/or prevention of depression and anxiety including an effective amount of the piperazine compound, and a method of treating depression, anxiety and other conditions related to 5-HT1A receptor in a mammal.
    Type: Grant
    Filed: January 28, 2011
    Date of Patent: July 8, 2014
    Assignee: SK Biopharmaceuticals Co., Ltd.
    Inventors: Yonggil Kim, Nahmryune Cho, Yunhee Kim, Joon Heo, Seonmin Dong, Mi Kyung Ji, Man-Young Cha, Kiho Lee
  • Patent number: 7985752
    Abstract: The present invention relates to novel piperazine derivatives or pharmaceutically acceptable salts thereof, a process for preparing the same, and in particular, a high binding for Serotonin 1A(5-hydroxytryptamine; 5-HT1A) receptor, a pharmaceutical composition for treatment and/or prevention of depression and anxiety including an effective amount of the piperazine compound, and a method of treating depression, anxiety and other conditions related to 5-HT1A receptor in a mammal.
    Type: Grant
    Filed: May 29, 2009
    Date of Patent: July 26, 2011
    Assignee: SK Holdings Co., Ltd.
    Inventors: Yonggil Kim, Nahmryune Cho, Yunhee Kim, Joon Heo, Seonmin Dong, Mi Kyung Ji, Man-Young Cha, Kiho Lee
  • Patent number: 7964605
    Abstract: The present invention relates to a novel piperazine derivative or pharmaceutically acceptable salt thereof, a process for preparing the same, a pharmaceutical composition for treating central nervous system diseases comprising an effective amount of the piperazine compound and a method of treating central nervous system (CNS) disorder such as psychosis in a mammal.
    Type: Grant
    Filed: May 29, 2008
    Date of Patent: June 21, 2011
    Assignee: SK Holdings Co., Ltd.
    Inventors: Yonggil Kim, Kiho Lee, Nahmryune Cho, Jin Uk Yoo, Joon Heo, Choonho Ryu, Seonmin Dong, Man-Young Cha, Jong Gil Choi, Yunhee Kim, Mi Kyung Ji
  • Publication number: 20110118264
    Abstract: The present invention relates to novel piperazine derivatives or pharmaceutically acceptable salts thereof, a process for preparing the same, and in particular, a high binding for Serotonin 1A(5-hydroxytryptamine; 5-HT1A) receptor, a pharmaceutical composition for treatment and/or prevention of depression and anxiety including an effective amount of the piperazine compound, and a method of treating depression, anxiety and other conditions related to 5-HT1A receptor in a mammal
    Type: Application
    Filed: January 28, 2011
    Publication date: May 19, 2011
    Inventors: Yonggil Kim, Nahmryune Cho, Yunhee Kim, Joon Heo, Seonmin Dong, Mi Kyung Ji, Man-Young Cha, Kiho Lee
  • Publication number: 20090298851
    Abstract: The present invention relates to a novel piperazine derivative or pharmaceutically acceptable salt thereof, a process for preparing the same, a pharmaceutical composition for treating central nervous system diseases comprising an effective amount of the piperazine compound and a method of treating central nervous system (CNS) disorder such as psychosis in a mammal.
    Type: Application
    Filed: May 29, 2008
    Publication date: December 3, 2009
    Inventors: Yonggil Kim, Kiho Lee, Nahmryune Cho, Jin Uk Yoo, Joon Heo, Choonho Ryu, Seonmin Dong, Man-Young Cha, Jong Gil Choi, Yunhee Kim, Mi Kyung Ji
  • Publication number: 20090298831
    Abstract: The present invention relates to novel piperazine derivatives or pharmaceutically acceptable salts thereof, a process for preparing the same, and in particular, a high binding for Serotonin 1A(5-hydroxytryptamine; 5-HT1A) receptor, a pharmaceutical composition for treatment and/or prevention of depression and anxiety including an effective amount of the piperazine compound, and a method of treating depression, anxiety and other conditions related to 5-HT1A receptor in a mammal.
    Type: Application
    Filed: May 29, 2009
    Publication date: December 3, 2009
    Inventors: Yonggil Kim, Nahmryune Cho, Yunhee Kim, Joon Heo, Seonmin Dong, Mi Kyung Ji, Man-Young Cha, Kiho Lee